PatientsVille.com Logo

Adenoma and Duodart

PatientsVille

Adenoma Symptoms and Causes

Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain.

Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong. New cells form when your body does not need them, and old cells do not die when they should. These extra cells can divide without stopping and may form tumor.

Treatment often involves surgery. Benign tumors usually don't grow back.

NIH: National Cancer Institute

Check out the latest treatments for adenoma

adenoma treatment research studies

Duodart clinical trials, surveys and public health registries


Find Drug Side Effect reports



Duodart Side Effects

Dizziness (333)
Malaise (167)
Urinary Retention (151)
Rash Pruritic (126)
Loss Of Consciousness (107)
Dyspnoea (107)
Hypotension (100)
Myalgia (98)
Fall (86)
Hypersensitivity (85)
Nasal Dryness (78)
Nervousness (77)
Tachycardia (75)
Bronchospasm (74)
Myocardial Ischaemia (73)
Nausea (72)
Product Quality Issue (65)
Pyrexia (65)
Syncope (63)
Hepatic Enzyme Increased (55)
Testicular Pain (1)
Urinary Tract Infection (1)
Urticaria (1)
Vertigo (1)
White Blood Cell Count Increased (1)
Swelling (1)
Weight Decreased (1)
Rhinorrhoea (1)
Pulmonary Fibrosis (1)
Pancreatitis Acute (1)
Rash Papular (1)
Sepsis (1)
Skin Reaction (1)
Skin Necrosis (1)
Supraventricular Tachycardia (1)
Melaena (1)
Liver Disorder (1)
Injury (1)
Micturition Disorder (1)
Oesophageal Pain (1)
Oedema Peripheral (1)
Oesophageal Irritation (1)
Hypertension (1)
Herpes Zoster (1)
Hair Colour Changes (1)
Pain (1)
Head Injury (1)
Headache (1)
Hepatic Cirrhosis (1)
Palpitations (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Adenoma Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
Outcome Measures: Use the number of participants with adverse events,serious adverse events and treatment-related adverse events as a measure of Safety;   Use changes in International Prostate symptom score (IPSS) and Qmax (Maximum rate of Urinary Flow (ml/sec) as a measure of Efficacy
2 Recruiting Prospective Sexual Function Study for BPH Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: Placebo
Outcome Measures: Changes in total score from the full men's sexual health questionnaire (MSHQ) which has domains for erectile dysfunction, ejaculatory function and libido.;   Change in scores from the full Men's Sexual Health Questionnaire (MSHQ) from baseline at 1, 3, 6 and 9 months;   The percentage of subjects reaching the following thresholds: +10 points, +20 points,+25 points, -10 points, -20 points, -25 points, change in total MSHQ from baseline at 12 months;   Change in scores from ED, EjD and libido domains from baseline at 1, 3, 6, 9 and 12 months.;   Change in scores from baseline IPSS questionnaire scores, Quality of Life (BPH Impact Index -BII scores) and perception of treatment benefit/satisfaction with treatment (PPSM questionnaire scores) at 2 weeks an 1, 3, 6 ,9 and 12 months;   Change in MSHQ scores from baseline at 12 months in subpopulations of men with good BPH symptomatic response;   Assess the duration of events both during the treatment phase and after treatment discontinuation by following up men with sexual adverse events who withdraw from the study or men with sexual apresent at the last visit of the treatment phase